Arvinas, Inc. (ARVN)
NASDAQ: ARVN · IEX Real-Time Price · USD
29.65
+0.13 (0.44%)
At close: Jul 26, 2024, 4:00 PM
29.96
+0.31 (1.05%)
After-hours: Jul 26, 2024, 5:31 PM EDT
Arvinas Market Cap
Arvinas has a market cap or net worth of $2.03 billion as of July 26, 2024. Its market cap has increased by 57.86% in one year.
Market Cap
2.03B
Enterprise Value
863.65M
1-Year Change
57.86%
Ranking
Category
Stock Price
$29.65
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $500.50M to $2.03B, an increase of 305.40%. That is a compound annual growth rate of 27.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 2.02B | -10.80% |
| Dec 29, 2023 | 2.26B | 24.38% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 26.11% |
| Dec 31, 2020 | 3.44B | 148.34% |
| Dec 31, 2019 | 1.39B | 233.58% |
| Dec 31, 2018 | 415.70M | -16.94% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LifeStance Health Group | 2.13B |
| BrightSpring Health Services | 2.08B |
| Premier | 2.08B |
| Catalyst Pharmaceuticals | 2.07B |
| STAAR Surgical Company | 2.06B |
| Structure Therapeutics | 2.05B |
| Edgewise Therapeutics | 2.03B |
| LeMaitre Vascular | 2.02B |